Study about the elucidation of hepatocarcinogenesis mechanism km fatty liver and preventive strategies based on pathogenic considerations
脂肪肝肝癌发生机制的阐明及基于病因的预防策略研究
基本信息
- 批准号:18590574
- 负责人:
- 金额:$ 2.57万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We used FLS mice (n=48) in this study. FLS mouse develops spontaneously fatty liver chronically without obesity. Liver tumors develop after age of 1 year. The FLS mice were subdivided into three groups : group 1 received control diet (CA-1) alone, group 2 received diet containing lactobacillus, and group 3 received control diet containing clostridium butyricum that produce butyric acid in a bowel after oral intake.At age 10 month, all mice showed significant fatty deposition in the liver without fibrosis. At age 12 month, 2 out of 8 mice in group 1 developed liver tumor, whereas 1 out of 8 mice developed liver tumor in both group 2 and 3. Measurement of short chain fatty acid in the feces by HPLC revealed that concentration of sodium butyrate increased in the mice of group 3.Immunohistochemical analysis of the liver of 10-month-old LPS mice showed that 4-HNE, a marker of oxidative stress, remarkably increased in group 1 mice compared with those in group 3 mice. On the contrary, the protein expression of transcription factor NF-KB increased in the liver of group 3 mice by the Western blot analysis. Phosphorylation of c-jun (Ser 73) was also observed in the liver of mice in group 3. Finally, protein expression of p21 WAF1 also increased in the liver of group 3 mice by the Western blot.These results indicate that oxidative stress takes a crucial role in the progression of liver disease in FLS mice. Oral intake of clostridium butyricum may protect the development of liver tumor in FLS mice.
我们在本研究中使用FLS小鼠(n=48)。FLS小鼠自发形成慢性脂肪肝,无肥胖。肝脏肿瘤在1岁以后发展。将FLS小鼠再分为3组:第1组仅接受对照饮食(CA-1),第2组接受含有丁酸的饮食,第3组接受含有丁酸梭菌的对照饮食,所述丁酸梭菌在口服摄入后在肠中产生丁酸。在12月龄时,第1组中8只小鼠中有2只发生肝肿瘤,而第2组和第3组中8只小鼠中有1只发生肝肿瘤。高效液相色谱法测定粪便中短链脂肪酸含量,结果显示第3组小鼠丁酸钠含量增加。免疫组化法检测10月龄LPS小鼠肝脏中氧化应激标志物4-HNE含量,结果显示第1组小鼠肝脏中氧化应激标志物4-HNE含量明显高于第3组。Western blot分析显示,第3组小鼠肝脏中转录因子NF-κ B的蛋白表达增加。在第3组小鼠的肝脏中也观察到c-jun(Ser 73)的磷酸化。最后,Western blot结果显示,第3组小鼠肝脏中p21 WAF 1蛋白表达增加,表明氧化应激在FLS小鼠肝脏疾病的进展中起着重要作用。口服丁酸梭菌对FLS小鼠肝癌的发生有保护作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice
- DOI:10.1002/hep.21477
- 发表时间:2007-01-01
- 期刊:
- 影响因子:13.5
- 作者:Higashiyama, Reiichi;Inagaki, Yutaka;Okazaki, Isao
- 通讯作者:Okazaki, Isao
肝線維化に対する薬物療法:NAFLDのすべて,第6章,病態生理に基づくNAFLDの薬物療法
肝纤维化的药物治疗:关于 NAFLD,第 6 章,基于病理生理学的 NAFLD 药物治疗
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Reiichi;Higashiyama;et. al.;渡辺 哲;Higashiyama R;渡辺 哲
- 通讯作者:渡辺 哲
All-trans retinoic acid down-regulates human albumin gene expression through the induction of C/EBPI3-LIP
全反式视黄酸通过诱导 C/EBPI3-LIP 下调人白蛋白基因表达
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Takahiro;Masaki;et. al.
- 通讯作者:et. al.
Migration of autologous bone marrow cells into the liver and treatment strategies of liver fibrosis based on the induction of MMP expression
自体骨髓细胞入肝的迁移及基于诱导MMP表达的肝纤维化治疗策略
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Reiichi;Higashiyama;et. al.
- 通讯作者:et. al.
アルコールと疫学-日本人の飲酒実態 : アルコールの健康への影響
酒精与流行病学 - 日本人饮酒的实际状况:酒精对健康的影响
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Tetsu;Watanabe;渡辺 哲;渡辺 哲
- 通讯作者:渡辺 哲
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WATANABE Tetsu其他文献
WATANABE Tetsu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WATANABE Tetsu', 18)}}的其他基金
Therapeutic inhibition of microRNA-34a ameliorates aortic valve calcification via modulation of Notch1-Runx2 signaling
microRNA-34a 的治疗性抑制通过调节 Notch1-Runx2 信号传导改善主动脉瓣钙化
- 批准号:
16K09490 - 财政年份:2016
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probiotics and prevention of hepatocarcinogenesis
益生菌与预防肝癌
- 批准号:
26460810 - 财政年份:2014
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The impact of macrophage transcription factor MafB on rupture of abdominal aortic aneurysm
巨噬细胞转录因子MafB对腹主动脉瘤破裂的影响
- 批准号:
24591033 - 财政年份:2012
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a method for preventing NASH progression and hepatocarcinogenesis by using butyrate-produding probiotics
开发利用产生丁酸盐的益生菌预防 NASH 进展和肝癌发生的方法
- 批准号:
23590755 - 财政年份:2011
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A role of Maf B in development and rupture of atherosclerotic plaques
Maf B 在动脉粥样硬化斑块的形成和破裂中的作用
- 批准号:
21790700 - 财政年份:2009
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Understanding the mechanism of liver carcinogenesis and strategy for the prevention of hepatoma development
了解肝癌发生机制及预防肝癌发展的策略
- 批准号:
20590615 - 财政年份:2008
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
GPR35: mechanisms of action and agonism as a potential therapeutic strategy for non-alcoholic fatty liver diseases
GPR35:作为非酒精性脂肪肝疾病潜在治疗策略的作用和激动机制
- 批准号:
MR/X008827/1 - 财政年份:2024
- 资助金额:
$ 2.57万 - 项目类别:
Research Grant
AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients (Artemis)
加速虚拟双胞胎向脂肪肝患者个性化管理的转化(Artemis)
- 批准号:
10109933 - 财政年份:2024
- 资助金额:
$ 2.57万 - 项目类别:
EU-Funded
Perfluoroalkyl substances and non-alcoholic fatty liver disease in children: Leveraging magnetic resonance imaging to unravel potential mechanisms and exposure mixture effects
全氟烷基物质与儿童非酒精性脂肪肝:利用磁共振成像揭示潜在机制和暴露混合物效应
- 批准号:
10646759 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
An NADH-ChREBP axis in fatty liver disease and dyslipidemia
脂肪肝疾病和血脂异常中的 NADH-ChREBP 轴
- 批准号:
10564369 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Development of Early Diagnostic Markers for Non-Alcoholic Fatty Liver Disease (NAFLD) and Investigation of Inflammatory Mechanisms of NAFLD
非酒精性脂肪性肝病(NAFLD)早期诊断标志物的开发及NAFLD炎症机制的研究
- 批准号:
23K07466 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tackling the fatty liver by targeting the gut
通过针对肠道来解决脂肪肝
- 批准号:
2869577 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Studentship
Interaction between Genome and Heavy Metals in Nonalcoholic Fatty Liver Disease
非酒精性脂肪肝中基因组与重金属的相互作用
- 批准号:
10658148 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
AAV mediated gene knockdown of PIK3C2B as a therapeutic strategy for X-linked myotubular myopathy and fatty liver disease
AAV 介导的 PIK3C2B 基因敲低作为 X 连锁肌管肌病和脂肪肝的治疗策略
- 批准号:
10753786 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Bacteriotherapy to treat non-alcoholic fatty liver disease
细菌疗法治疗非酒精性脂肪肝
- 批准号:
2893992 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Studentship
The Gut-Liver Axis in HIV-Related Non-Alcoholic Fatty Liver Disease
HIV 相关非酒精性脂肪肝中的肠肝轴
- 批准号:
10762284 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别: